Australia markets closed

SoftOx Solutions AS (6FV.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.01000.0000 (0.00%)
As of 08:13AM CEST. Market open.

SoftOx Solutions AS

Martin Linges vei 25
Fornebu 1364
Norway
47 94 85 95 99
https://soft-ox.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Christian HarstadInterim Chief Executive OfficerN/AN/AN/A
Harald SaetvedtChief Financial OfficerN/AN/AN/A
Mr. Thomas BjarnsholtChief Scientific OfficerN/AN/AN/A
Ms. Elin Lisby Kastberg JørgensenInternational Senior Project ManagerN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

SoftOx Solutions AS, together with its subsidiaries, operates as a medtech and clinical-stage pharmaceutical company in Norway. It offers disinfection products, which includes SafeDes+, a hand disinfectant for irritated, compromised and eczematous skin; and EffectDesH, a surface disinfectant, which has a broad spectrum inactivation effect on bacteria, viruses, yeast, fungi, mycobacterium, and spores. The company also provides human wound and infection treatment products comprising SoftOx Wound Irrigation solutions for acute and chronic wounds to prevent and treat infections including biofilms; and SoftOx Anti-infectives, which aims to treat and remove topical infections in wounded and mucosal tissues, such as biofilms, AMR microbes, viruses, and fungi. In addition, its developing antiseptic solutions for pets and livestock, as well as humans; and inhalation solution, a novel and self-administered inhaled drug for early treatment and prevention of influenza-like illnesses. The company was incorporated in 2012 and is headquartered in Fornebu, Norway.

Corporate governance

SoftOx Solutions AS’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.